Neoplastic Cell Transformation
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma.
|
24362818 |
2014 |
Lymphoma, Follicular
|
0.300 |
Biomarker
|
disease |
CTD_human |
Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma.
|
24362818 |
2014 |
Respiratory Distress Syndrome, Adult
|
0.300 |
Biomarker
|
disease |
CTD_human |
MicroRNA and mRNA expression profiling in rat acute respiratory distress syndrome.
|
25070658 |
2014 |
Lymphoma, Large-Cell, Follicular
|
0.300 |
Biomarker
|
disease |
CTD_human |
Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma.
|
24362818 |
2014 |
Lymphoma, Mixed-Cell, Follicular
|
0.300 |
Biomarker
|
disease |
CTD_human |
Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma.
|
24362818 |
2014 |
Lymphoma, Small Cleaved-Cell, Follicular
|
0.300 |
Biomarker
|
disease |
CTD_human |
Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma.
|
24362818 |
2014 |
Lymphoma, Follicular, Grade 1
|
0.300 |
Biomarker
|
disease |
CTD_human |
Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma.
|
24362818 |
2014 |
Lymphoma, Follicular, Grade 3
|
0.300 |
Biomarker
|
disease |
CTD_human |
Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma.
|
24362818 |
2014 |
Lymphoma, Follicular, Grade 2
|
0.300 |
Biomarker
|
disease |
CTD_human |
Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma.
|
24362818 |
2014 |
Lipodystrophy
|
0.200 |
Biomarker
|
disease |
MGD |
Ebf1-dependent control of the osteoblast and adipocyte lineages.
|
19130908 |
2009 |
Malignant neoplasm of breast
|
0.120 |
Biomarker
|
disease |
BEFREE |
This study identifies LMRs specific to the three main BC subtypes and reveals EBF1 as a potentially important regulator of BC subtype-specific methylation and gene expression program.
|
29099283 |
2017 |
Breast Carcinoma
|
0.120 |
GeneticVariation
|
disease |
GWASCAT |
Association analysis identifies 65 new breast cancer risk loci.
|
29059683 |
2017 |
Breast Carcinoma
|
0.120 |
Biomarker
|
disease |
BEFREE |
This study identifies LMRs specific to the three main BC subtypes and reveals EBF1 as a potentially important regulator of BC subtype-specific methylation and gene expression program.
|
29099283 |
2017 |
Malignant neoplasm of breast
|
0.120 |
GeneticVariation
|
disease |
BEFREE |
Of 41 recently discovered breast cancer susceptibility variants, associations were found between rs1432679 (EBF1), rs17817449 (MIR1972-2: FTO), rs12710696 (2p24.1), and rs3757318 (ESR1) and adjusted absolute and percent dense areas, respectively.
|
25862352 |
2015 |
Breast Carcinoma
|
0.120 |
GeneticVariation
|
disease |
GWASCAT |
Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer.
|
25751625 |
2015 |
Breast Carcinoma
|
0.120 |
GeneticVariation
|
disease |
BEFREE |
Of 41 recently discovered breast cancer susceptibility variants, associations were found between rs1432679 (EBF1), rs17817449 (MIR1972-2: FTO), rs12710696 (2p24.1), and rs3757318 (ESR1) and adjusted absolute and percent dense areas, respectively.
|
25862352 |
2015 |
Malignant neoplasm of breast
|
0.120 |
GeneticVariation
|
disease |
GWASDB |
Large-scale genotyping identifies 41 new loci associated with breast cancer risk.
|
23535729 |
2013 |
Breast Carcinoma
|
0.120 |
GeneticVariation
|
disease |
GWASCAT |
Large-scale genotyping identifies 41 new loci associated with breast cancer risk.
|
23535729 |
2013 |
Anorexia Nervosa
|
0.110 |
GeneticVariation
|
disease |
GWASCAT |
A genome-wide association study of anorexia nervosa suggests a risk locus implicated in dysregulated leptin signaling.
|
28630421 |
2017 |
Anorexia Nervosa
|
0.110 |
GeneticVariation
|
disease |
BEFREE |
Analysis of phenotypic variability led to the identification of a specific genetic risk factor that approached genome-wide significance (rs929626 in EBF1 (Early B-Cell Factor 1); P = 2.04 × 10<sup>-7</sup>; OR = 0.7; 95% confidence interval (CI) = 0.61-0.8) with independent replication (P = 0.04), suggesting a variant-mediated dysregulation of leptin signaling may play a role in AN.
|
28630421 |
2017 |
Leukemia, Myelocytic, Acute
|
0.110 |
GeneticVariation
|
disease |
GWASCAT |
Genome-wide haplotype association study identify the FGFR2 gene as a risk gene for acute myeloid leukemia.
|
27903959 |
2017 |
Leukemia, Myelocytic, Acute
|
0.110 |
Biomarker
|
disease |
BEFREE |
Common lesions include translocations to T cell receptor (TCR) loci in T-lineage acute lymphoblastic leukemia (T-ALL), mutations of transcription factors regulating B-lineage development and cell maturation in B-lineage acute lymphoblastic leukemia (B-ALL) (PAX5, TCF3, EBF1, etc.), aberrational disruption of genes coding for transcription factors and coactivators in acute myeloid leukemia (AML) (e.g.
|
25748621 |
2015 |
Birth Weight
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Maternal and fetal genetic effects on birth weight and their relevance to cardio-metabolic risk factors.
|
31043758 |
2019 |
Body Height
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
Cardiovascular Diseases
|
0.100 |
GeneticVariation
|
group |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |